By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Nano Labs Expands BNB Strategic Reserve to US$90 Million and Announces Plan to Upgrade BNB Reserve Strategy
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Technology > Nano Labs Expands BNB Strategic Reserve to US$90 Million and Announces Plan to Upgrade BNB Reserve Strategy
Nano Labs Expands BNB Strategic Reserve to US Million and Announces Plan to Upgrade BNB Reserve Strategy
Technology

Nano Labs Expands BNB Strategic Reserve to US$90 Million and Announces Plan to Upgrade BNB Reserve Strategy

GlobeNews Wire
Last updated: 22/07/2025 3:37 PM
GlobeNews Wire
Published: 22/07/2025
Share
SHARE

July 22, 2025 06:00 ET  | Source: Nano Labs Ltd.

HONG KONG, July 22, 2025 (GLOBE NEWSWIRE) — Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider, today announced that it has significantly increased its holdings of BNB to 120,000.00, representing a total value of approximately US$90 million. This move marks significant progress and a major milestone in the Company’s full-scale upgrade of its BNB strategic reserve plan.

In recent days, Nano Labs has continued to expand its BNB holdings by acquiring an additional 45,684.9862 BNB through OTC transactions at an average purchase price of approximately US$764 per token. As a result, the Company now holds approximately 120,000.00 BNB, acquired at an average purchase cost of US$707 per token, and valued at approximately US$90 million.

Nano Labs plans to further strengthen its BNB strategic reserve through multiple approaches, including but not limited to continued accumulation of BNB, acquiring controlling stakes in BNB-focused strategic reserve entities, and investing in companies dedicated to holding BNB as a core reserve asset.

About Nano Labs Ltd

Nano Labs Ltd is a leading Web 3.0 infrastructure and product solution provider in China. Nano Labs is committed to the development of high throughput computing (“HTC”) chips and high performance computing (“HPC”) chips. Nano Labs has built a comprehensive flow processing unit (“FPU”) architecture which offers solution that integrates the features of both HTC and HPC. In addition, Nano Labs has actively positioned itself in the digital assets space, adopting BNB as its primary reserve asset. It has reserved in mainstream digital currencies including BNB and BTC, and established an integrated platform covering multiple business verticals, including HTC solutions and HPC solutions*. For more information, please visit the Company’s website at: ir.nano.cn.

*  According to an industry report prepared by Frost & Sullivan.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, the Company’s plan to appeal the Staff’s determination, which can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

For investor inquiries, please contact:

Nano Labs Ltd
ir@nano.cn

Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com

Birla Carbon Releases 2025 Sustainability Report ‘Connected to a Greener Future’
WISeKey, WISeSat.Space and SEALSQ To Host Trust and Convergence 2026: The Year of Quantum Security Discussions During Flagship Davos Gathering
KPI Green Energy Ltd.: India’s first externally credit-enhanced Green Bond
TheraWolf PainBalm and NeuroBalm Claims Evaluated: What Buyers Are Overlooking About Topical Relief Formulas, Ingredients, and Pricing in 2026
Metavesco Releases White Paper on Tokenizing the OTC in Advance of Crypto Roundtable with SEC
TAGGED:andannouncesbnbexpandslabsmillionnanoNasdaq:NAnewsplanreserve,strategicstrategyupgradeus$90US63011A1025
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
adidas Celebrates 20 Years of its Iconic TOUR360 Footwear Franchise
Esports

adidas Celebrates 20 Years of its Iconic TOUR360 Footwear Franchise

TheNews Market
TheNews Market
09/11/2025
Press Release: Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is now high single-digit growth, at upper end of range
XYRA Corp. Positioned to Capitalize on Explosive Growth in Data Center Immersion Cooling Market
Startek Malaysia wins three HR Asia 2025 awards, reaffirming its people-first culture
Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?